Buy now: The trend is firmly bullish (SMA_5 > SMA_20 > SMA_200) and MACD momentum is expanding, which supports immediate upside continuation.
Near-term upside is still favorable: Pattern-based projection implies +1.1% next week and +4.36% next month, aligning with the current uptrend.
Main trade setup: Price is just below R1 ~117.97; a push/close above that level improves odds of a move toward R2 ~119.45.
What keeps this from being a “slam-dunk”: RSI(6) ~71 suggests momentum is getting stretched, so upside may come with brief pullbacks—but the overall bias remains upward.
Positioning: Put/Call OI ratio 0.87 → slightly more call-leaning than put-leaning (mildly bullish positioning).
Flow today: Options volume is extremely thin (calls 7, puts 0) → sentiment read is limited because participation is low.
Volatility: IV(30d) 32.67 vs HV 36.63 → implied is below realized; options not pricing in unusually large moves.
IV percentile/rank: IV percentile 41.2, IV rank 7.59 → volatility is not elevated versus its own history (no strong “fear bid”).
Technical Summary
Sell
6
Buy
10
Positive Catalysts
Strong operating momentum (latest reported quarter): 2025/Q3 showed sharp YoY gains across revenue, earnings, and margins (supports continued multiple/price support if trend persists).
Technical breakout potential: Price is sitting just under R1 ~117.97; clearing it can trigger momentum buying toward ~119.45.
Upcoming event: Next earnings scheduled 2026-02-25 (after hours); if the growth trend persists, it can act as an upside catalyst.
Neutral/Negative Catalysts
around 71 increases odds of a near-term pullback/consolidation.
Cons: short-term overbought readings, trading near resistance, approaching earnings date (catalyst cuts both ways).
Wall Street analysts forecast ACA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACA is 110 USD with a low forecast of 110 USD and a high forecast of 110 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast ACA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACA is 110 USD with a low forecast of 110 USD and a high forecast of 110 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 120.830
Low
110
Averages
110
High
110
Current: 120.830
Low
110
Averages
110
High
110
Deutsche Bank
Buy
maintain
AI Analysis
2026-01-21
Reason
Deutsche Bank
Price Target
AI Analysis
2026-01-21
maintain
Buy
Reason
Deutsche Bank raised the firm's price target on Credit Agricole to EUR 20 from EUR 19 and keeps a Buy rating on the shares.
RBC Capital
Anke Reingen
Sector Perform
maintain
$18 -> $19
2025-12-19
Reason
RBC Capital
Anke Reingen
Price Target
$18 -> $19
2025-12-19
maintain
Sector Perform
Reason
RBC Capital analyst Anke Reingen raised the firm's price target on Credit Agricole to C$19 from C$18 and keeps a Sector Perform rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ACA
